{
    "Trade/Device Name(s)": [
        "eBcarryon Blood Glucose Monitoring System"
    ],
    "Submitter Information": "VISGENEER, INC.",
    "510(k) Number": "K091765",
    "Predicate Device Reference 510(k) Number(s)": [
        "K062555"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "CGA"
    ],
    "Summary Letter Date": "January 19, 2010",
    "Summary Letter Received Date": "December 22, 2009",
    "Submission Date": "December 22, 2009",
    "Regulation Number(s)": [
        "21 CFR 862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose Test System"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood from the finger"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Electrochemical biosensor"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "System"
    ],
    "Document Summary": "FDA 510(k) summary for VISGENEER eBcarryon Blood Glucose Monitoring System utilizing electrochemical biosensor technology for blood glucose measurement.",
    "Indications for Use Summary": "For quantitative measurement of glucose in fresh capillary whole blood from the finger to aid in monitoring diabetes control; not intended for diagnosis or screening of diabetes or use on neonates.",
    "fda_folder": "Clinical Chemistry"
}